Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin

Am J Clin Oncol. 2010 Apr;33(2):125-7. doi: 10.1097/COC.0b013e31819791eb.

Abstract

Background: Microcystic adnexal carcinoma (MAC) is a very rare cancer of the skin. It has only been described previously in case reports and small retrospective series.

Objective: To analyze and summarize data from the National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) database regarding MAC.

Methods: The SEER 1973 to 2004 database was investigated, and patients with MAC were identified. A statistical analysis was performed.

Results: Two hundred twenty-three patients were identified. Predominant site of disease was the head and neck skin (74%). There was only 1 case of recorded metastatic disease. Lymph nodes were pathologically involved in 1%. The 10-year overall survival was 86.4% (Standard Error [SE]: 3.3%). US census population-matched relative survival was 97.7% at 10 years (SE: 5.2%).

Limitations: This study is limited by the retrospective nature of the SEER database.

Conclusions: MAC is locally invasive, and rarely metastasizes to lymph nodes. Overall and population-matched relative survival is excellent.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Ductal / epidemiology
  • Carcinoma, Ductal / pathology*
  • Carcinoma, Skin Appendage / epidemiology
  • Carcinoma, Skin Appendage / pathology*
  • Child
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Retrospective Studies
  • SEER Program
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / pathology*
  • Survival Rate
  • Treatment Outcome
  • Young Adult